Position in INDV
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$747,034
New position
Shares Held
24,509
first reported quarter
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. INDV ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
24,509 | $747,034 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $747,034 | 24,509 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||